Effect of glycogen synthase kinase-3 beta inhibitor Tideglusib on proliferation and osteogenic differentiation of rat bone marrow mesenchymal stem cells under high glucose microenvironment

doi:10.12307/2023.620

Abstract

Abstract: BACKGROUND: High glucose condition can inhibit the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells, and how to improve the biological activity of osteoblasts in high glucose conditions is the key to improve osseointegration in diabetic patients.
OBJECTIVE: To investigate the effect of Tideglusib, a non-ATP-competitive specific glycogen synthase kinase-3β (GSK-3β) inhibitor, on the osteogenic differentiation of rat bone marrow mesenchymal stem cells under high glucose conditions.
METHODS: Rat bone marrow mesenchymal stem cells were cultured and purified by whole bone marrow apposition method. Bone marrow mesenchymal stem cells were divided into four groups as follows: normal control group (5.5 mmol/L glucose), Tideglusib group (5.5 mmol/L glucose + 20 nmol/L Tideglusib), high glucose group (25.5 mmol/L glucose), and Tideglusib + high glucose group (25.5 mmol/L glucose+20 nmol/L Tideglusib). (1) The proliferation activities of cells were detected by CCK-8 assay. (2) Alkaline phosphatase activity was detected at 4 and 7 days after osteogenic differentiation in each group. (3) Calcium nodules were detected by alizarin red staining at 21 days after osteogenic differentiation in each group. (4) Phalloidin staining was used to observe the adhesion morphology of each group after 24 hours of inoculation. (5) RT-qPCR was used to detect the mRNA expression of osteogenic genes Runx2 and OPN. Western blot assay was used to detect the protein expression of β-catenin and p-GSK-3β.
RESULTS AND CONCLUSION: (1) Tideglusib (20 nmol/L) not only significantly promoted the proliferation of bone marrow mesenchymal stem cells (P < 0.05), but also reversed the inhibitory effect of the high glucose on the proliferation of bone marrow mesenchymal stem cells (P < 0.05). (2) Tideglusib (20 nmol/L) significantly reduced the inhibitory effect of high glucose conditions on alkaline phosphatase activity (P < 0.05) and promoted the formation of calcified nodules under high glucose conditions (P < 0.05). (3) Tideglusib (20 nmol/L) could improve the adhesion morphology of bone marrow mesenchymal stem cells damaged by high glucose conditions. (4) Compared with the high glucose group, Tideglusib (20 nmol/L) up-regulated the mRNA expression of osteogenic genes Runx2 and OPN under the high glucose conditions (P < 0.05). (5) Compared with the high glucose group, Tideglusib (20 nmol/L) upregulated the expression of Wnt/β-catenin pathway related target β-catenin protein and down-regulated the expression of p-GSK-3β protein under high glucose conditions (P < 0.05). (6) The results showed that Tideglusib (20 nmol/L) could reverse the damage of high glucose conditions on the initial adhesion morphology, cell proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells by activating Wnt/β-catenin signaling pathway.

Key words: Tideglusib, bone marrow mesenchymal stem cell, high glucose microenvironment, cell proliferation, osteogenic differentiation, Wnt/β-catenin, adhesion morphology, osteopontin

CLC Number:

Luo Wenhao, Feng Le, Huang Haixia, Liu Min, Wang Pin. Effect of glycogen synthase kinase-3 beta inhibitor Tideglusib on proliferation and osteogenic differentiation of rat bone marrow mesenchymal stem cells under high glucose microenvironment[J]. Chinese Journal of Tissue Engineering Research, 2023, 27(19): 2968-2974.

Figures/Tables 10

References

[1] Monje A, Catena A, Borgnakke WS. Association between diabetes mellitus/hyperglycaemia and peri-implant diseases: Systematic review and meta-analysis. J Clin Periodontol. 2017;44(6):636-648.
[2] Park SY, Choi KH, Jun JE, et al. Effects of Advanced Glycation End Products on Differentiation and Function of Osteoblasts and Osteoclasts. J Korean Med Sci. 2021;36(37):e239.
[3] Kaur J, Khosla S, Farr JN. Effects of diabetes on osteocytes. Curr Opin Endocrinol Diabetes Obes. 2022;29(4):310-317.
[4] Kasperk C, Georgescu C, Nawroth P. Diabetes Mellitus and Bone Metabolism. Exp Clin Endocrinol Diabetes. 2017;125(4):213-217.
[5] Murray CE, Coleman CM. Impact of Diabetes Mellitus on Bone Health. Int J Mol Sci. 2019;20(19):4873.
[6] 董刚,徐欣,田燕,等.2型糖尿病患者血糖控制水平与种植牙愈合的关系[J].吉林大学学报(医学版),2013,39(1):143-147.
[7] Al Zahrani S, Al Mutairi AA. Crestal Bone Loss Around Submerged and Non-Submerged Dental Implants in Individuals with Type-2 Diabetes Mellitus: A 7-Year Prospective Clinical Study. Med Princ Pract. 2019;28(1):75-81.
[8] King S, Klineberg I, Levinger I, et al. The effect of hyperglycaemia on osseointegration: a review of animal models of diabetes mellitus and titanium implant placement. Arch Osteoporos. 2016;11(1):29.
[9] Neves VC, Babb R, Chandrasekaran D, et al. Promotion of natural tooth repair by small molecule GSK3 antagonists. Sci Rep. 2017;7:39654.
[10] Zaugg LK, Banu A, Walther AR, et al. Translation Approach for Dentine Regeneration Using GSK-3 Antagonists. J Dent Res. 2020;99(5):544-551.
[11] Comeau-Gauthier M, Tarchala M, Luna JLR, et al. Unleashing β-catenin with a new anti-Alzheimer drug for bone tissue regeneration. Injury. 2020;51(11):2449-2459.
[12] Lektemur Alpan A, Çalişir M, Kizildağ A, et al. Effects of a Glycogen Synthase Kinase 3 Inhibitor Tideglusib on Bone Regeneration With Calvarial Defects. J Craniofac Surg. 2020;31(5):1477-1482.
[13] Sun Y, Zhu Y, Liu X, et al. Morroniside attenuates high glucose-induced BMSC dysfunction by regulating the Glo1/AGE/RAGE axis. Cell Prolif. 2020; 53(8):e12866.
[14] Li Y, Wang X. Chrysin Attenuates High Glucose-Induced BMSC Dysfunction via the Activation of the PI3K/AKT/Nrf2 Signaling Pathway. Drug Des Devel Ther. 2022;16:165-182.
[15] Liu S, Yang X, Zhong X, et al. Involvement of miR-337 in high glucose-suppressed osteogenic differentiation in bone marrow mesenchymal stem cells via negative regulation of Rap1A. In Vitro Cell Dev Biol Anim. 2021;57(3):350-358.
[16] Li Z, Zhao H, Chu S, et al. miR-124-3p promotes BMSC osteogenesis via suppressing the GSK-3β/β-catenin signaling pathway in diabetic osteoporosis rats. In Vitro Cell Dev Biol Anim. 2020;56(9):723-734.
[17] Zhang B, Liu N, Shi H, et al. High glucose microenvironments inhibit the proliferation and migration of bone mesenchymal stem cells by activating GSK3β. J Bone Miner Metab. 2016;34(2):140-150.
[18] 陈杨. Runx2对高糖环境下干细胞成骨分化作用和机制的初步研究[D].重庆:重庆医科大学,2017.
[19] Fairfield H, Falank C, Harris E, et al. The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesis. J Cell Physiol. 2018; 233(2):1156-1167.
[20] Jin P, Zhang X, Wu Y, et al. Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal stem cells have impaired abilities in proliferation, paracrine, antiapoptosis, and myogenic differentiation. Transplant Proc. 2010;42(7):2745-2752.
[21] del Ser T, Steinwachs KC, Gertz HJ, et al. Treatment of Alzheimer’s disease with the GSK-3 inhibitor tideglusib: a pilot study. J Alzheimers Dis. 2013;33(1):205-215.
[22] Atila D, Chen CY, Lin CP, et al. In vitro evaluation of injectable Tideglusib-loaded hyaluronic acid hydrogels incorporated with Rg1-loaded chitosan microspheres for vital pulp regeneration. Carbohydr Polym. 2022;278: 118976.
[23] 孙佳辰,刘馨竹,申传安,等.小分子药物Tideglusib促进大鼠创面愈合的机制研究[J].中华损伤与修复杂志(电子版),2021,16(3):224-231.
[24] 胡洋,张媛媛,李芳,等.中药有效成分调节细胞骨架功能的研究进展[J].药学研究,2018,37(4):187-193.
[25] Duan P, Bonewald LF. The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth. Int J Biochem Cell Biol. 2016;77(Pt A):23-29.
[26] 姜朝阳,谢兴文,徐世红,等.骨髓间充质干细胞成骨分化相关信号通路[J].中华骨质疏松和骨矿盐疾病杂志,2020,13(5):473-478.
[27] Nusse R, Clevers H. Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities. Cell. 2017;169(6):985-999.
[28] Maeda K, Kobayashi Y, Koide M, et al. The Regulation of Bone Metabolism and Disorders by Wnt Signaling. Int J Mol Sci. 2019;20(22):5525.
[29] 史卫东. AGEs、GSK3β、TRPM2对高糖环境下成骨细胞增殖影响的机制研究[D].兰州:兰州大学,2019.
[30] Cheng J, Xu HY, Liu MM, et al. Catalpol Promotes the Proliferation and Differentiation of Osteoblasts Induced by High Glucose by Inhibiting KDM7A. Diabetes Metab Syndr Obes. 2020;13:705-712.
[31] Chen Y, Chen L, Huang R, et al. Investigation for GSK3β expression in diabetic osteoporosis and negative osteogenic effects of GSK3β on bone marrow mesenchymal stem cells under a high glucose microenvironment. Biochem Biophys Res Commun. 2021;534:727-733.
[32] Antika LD, Lee EJ, Kim YH, et al. Dietary phlorizin enhances osteoblastogenic bone formation through enhancing β-catenin activity via GSK-3β inhibition in a model of senile osteoporosis. J Nutr Biochem. 2017;49:42-52.